{"transactions":[{"id":727526,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T21:07:49.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":30700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company."}],"balance_after":30700,"derivative":{"exercise_price":0.98,"expiration_date":"2036-06-21","underlying":"Common Stock","underlying_shares":30700},"source":{"system":"sec-edgar","filing":"0001248144-26-000003","document":"form4-06242026_090645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000124814426000003/form4-06242026_090645.xml","form_type":"4"}},{"id":727525,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T21:07:49.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":5100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company."}],"balance_after":22709,"source":{"system":"sec-edgar","filing":"0001248144-26-000003","document":"form4-06242026_090645.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000124814426000003/form4-06242026_090645.xml","form_type":"4"}},{"id":730270,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-06-22T20:09:05.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":53600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option to purchase shares of the Issuer's common stock (the \"Stock Option\") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":53600,"derivative":{"exercise_price":1.02,"exercise_date":"2027-06-17","expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":53600},"source":{"system":"sec-edgar","filing":"0001248144-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1248144/000124814426000001/primarydocument.xml","form_type":"4"}},{"id":730269,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T20:09:05.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":35700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (the \"RSUs\") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the \"2023 Plan\"), as provided by the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Program (the \"Program\"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":236200,"source":{"system":"sec-edgar","filing":"0001248144-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1248144/000124814426000001/primarydocument.xml","form_type":"4"}},{"id":1013786,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-24T20:45:22.000Z","date":"2025-10-23","kind":"grant","planned":false,"acquired":true,"shares":25600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company."}],"balance_after":25600,"derivative":{"exercise_price":1.14,"expiration_date":"2035-10-22","underlying":"Common Stock","underlying_shares":25600},"source":{"system":"sec-edgar","filing":"0001248144-25-000004","document":"form4-10242025_081019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000124814425000004/form4-10242025_081019.xml","form_type":"4"}},{"id":1013785,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-24T20:45:22.000Z","date":"2025-10-23","kind":"grant","planned":false,"acquired":true,"shares":4267,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company."}],"balance_after":17609,"source":{"system":"sec-edgar","filing":"0001248144-25-000004","document":"form4-10242025_081019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000124814425000004/form4-10242025_081019.xml","form_type":"4"}},{"id":1114763,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-06-11T21:16:12.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":53600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option to purchase shares of the Issuer's common stock (the \"Stock Option\") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer."}],"balance_after":53600,"derivative":{"exercise_price":3.92,"exercise_date":"2026-06-10","expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":53600},"source":{"system":"sec-edgar","filing":"0001562180-25-004723","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1248144/000156218025004723/primarydocument.xml","form_type":"4"}},{"id":1114762,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-11T21:16:12.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":35700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (the \"RSUs\") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the \"2023 Plan\"), as provided by the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Program (the \"Program\"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer."}],"balance_after":200500,"source":{"system":"sec-edgar","filing":"0001562180-25-004723","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1248144/000156218025004723/primarydocument.xml","form_type":"4"}},{"id":1470574,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-24T23:12:09.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":13044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company."}],"balance_after":13044,"derivative":{"exercise_price":0.885,"expiration_date":"2034-06-23","underlying":"Common Stock","underlying_shares":13044},"source":{"system":"sec-edgar","filing":"0001415889-24-018074","document":"form4-06242024_110605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000141588924018074/form4-06242024_110605.xml","form_type":"4"}},{"id":1470573,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-24T23:12:09.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":2174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company."}],"balance_after":13342,"source":{"system":"sec-edgar","filing":"0001415889-24-018074","document":"form4-06242024_110605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000141588924018074/form4-06242024_110605.xml","form_type":"4"}},{"id":1484686,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-06-10T20:18:10.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option to purchase shares of the Issuer's common stock (the \"Stock Option\") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer."}],"balance_after":45000,"derivative":{"exercise_price":1.07,"exercise_date":"2025-06-06","expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001562180-24-004901","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1248144/000156218024004901/primarydocument.xml","form_type":"4"}},{"id":1484685,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T20:18:10.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (the \"RSUs\") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the \"2023 Plan\"), as provided by the Issuer's Third Amended and Restated Non-Employee Director Compensation Program (the \"Program\"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer."}],"balance_after":164800,"source":{"system":"sec-edgar","filing":"0001562180-24-004901","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1248144/000156218024004901/primarydocument.xml","form_type":"4"}},{"id":1712380,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-13T21:19:46.000Z","date":"2023-10-10","kind":"grant","planned":false,"acquired":true,"shares":3487,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company."}],"balance_after":3487,"derivative":{"exercise_price":0.684,"exercise_date":"2024-10-10","expiration_date":"2033-10-10","underlying":"Common Stock","underlying_shares":3487},"source":{"system":"sec-edgar","filing":"0001209191-23-058474","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919123058474/doc4.xml","form_type":"4"}},{"id":1712379,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:19:46.000Z","date":"2023-10-10","kind":"grant","planned":false,"acquired":true,"shares":581,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Effective on October 25, 2022, the issuer effected a 20 to 1 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":11168,"source":{"system":"sec-edgar","filing":"0001209191-23-058474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919123058474/doc4.xml","form_type":"4"}},{"id":1862030,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2023-06-08T20:07:28.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option to purchase shares of the Issuer's common stock (the \"Stock Option\") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer."}],"balance_after":45000,"derivative":{"exercise_price":1.2,"exercise_date":"2024-06-06","expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001562180-23-004956","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1248144/000156218023004956/primarydocument.xml","form_type":"4"}},{"id":1862029,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-08T20:07:28.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (the \"RSUs\") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the \"2023 Plan\"), as provided by the Issuer's Second Amended and Restated Non-Employee Director Compensation Program (the \"Program\"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer."}],"balance_after":134800,"source":{"system":"sec-edgar","filing":"0001562180-23-004956","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1248144/000156218023004956/primarydocument.xml","form_type":"4"}},{"id":2010886,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COB, CEO and President"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-16T18:19:35.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 2.0833% of the total shares on March 14, 2023 and then 2.0833% of the total shares vests monthly thereafter, with 100% of the total shares vested and exercisable on February 14, 2027, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":200000,"derivative":{"exercise_price":2.29,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-23-010243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445499/000120919123010243/doc4.xml","form_type":"4"}},{"id":2206890,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-15T23:31:17.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company."}],"balance_after":31000,"derivative":{"exercise_price":0.2309,"exercise_date":"2022-07-15","expiration_date":"2032-07-14","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001209191-22-042308","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919122042308/doc4.xml","form_type":"4"}},{"id":2206889,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-15T23:31:17.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company."}],"balance_after":211750,"source":{"system":"sec-edgar","filing":"0001209191-22-042308","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919122042308/doc4.xml","form_type":"4"}},{"id":2237506,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2022-06-09T20:56:29.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The option to purchase shares of the Issuer's common stock (the \"Stock Option\") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":20100,"derivative":{"exercise_price":0.45,"exercise_date":"2023-06-08","expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":20100},"source":{"system":"sec-edgar","filing":"0001562180-22-004973","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1248144/000156218022004973/primarydocument.xml","form_type":"4"}},{"id":2237505,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-09T20:56:29.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":13700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (the \"RSUs\") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the \"2014 Plan\"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the \"Program\"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":104800,"source":{"system":"sec-edgar","filing":"0001562180-22-004973","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1248144/000156218022004973/primarydocument.xml","form_type":"4"}},{"id":2422435,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COB, CEO and President"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-28T17:01:40.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 2.0833% of the total shares on February 26, 2022 and then 2.0833% of the total shares vests monthly thereafter, with 100% of the total shares vested and exercisable on January 26, 2026, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":175000,"derivative":{"exercise_price":9.85,"expiration_date":"2032-01-25","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-22-005445","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445499/000120919122005445/doc4.xml","form_type":"4"}},{"id":2596082,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COB, CEO and President"}}],"security":"Common Stock","published_at":"2021-08-19T17:23:12.000Z","date":"2021-08-18","kind":"purchase","acquired":true,"shares":600,"price":15.8865,"value":9531.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.81 to $15.91 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-21-052595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1445499/000120919121052595/doc4.xml","form_type":"4"}},{"id":2596081,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COB, CEO and President"}}],"security":"Common Stock","published_at":"2021-08-19T17:23:12.000Z","date":"2021-08-18","kind":"purchase","acquired":true,"shares":2197,"price":14.9073,"value":32751.3381,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.69 to $15.60 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":19400,"source":{"system":"sec-edgar","filing":"0001209191-21-052595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1445499/000120919121052595/doc4.xml","form_type":"4"}},{"id":2596080,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COB, CEO and President"}}],"security":"Common Stock","published_at":"2021-08-19T17:23:12.000Z","date":"2021-08-18","kind":"purchase","acquired":true,"shares":17203,"price":13.8061,"value":237506.3383,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $13.61 to $14.435 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":17203,"source":{"system":"sec-edgar","filing":"0001209191-21-052595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445499/000120919121052595/doc4.xml","form_type":"4"}},{"id":2624818,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COB, CEO and President"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-26T17:58:10.000Z","date":"2021-07-20","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 2.0833% of the total shares on August 22, 2021 and then 2.0833% of the total shares vests monthly thereafter, with 100% of the total shares vested and exercisable on July 22, 2025, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":12.16,"expiration_date":"2031-07-19","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-21-048217","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445499/000120919121048217/doc4.xml","form_type":"4"}},{"id":2663479,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T21:32:29.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company."}],"balance_after":20000,"derivative":{"exercise_price":1.41,"exercise_date":"2022-06-17","expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-041579","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919121041579/doc4.xml","form_type":"4"}},{"id":2663478,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T21:32:29.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company."}],"balance_after":196250,"source":{"system":"sec-edgar","filing":"0001209191-21-041579","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919121041579/doc4.xml","form_type":"4"}},{"id":2682843,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2021-06-03T21:27:10.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The option to purchase shares of the Issuer's common stock (the \"Stock Option\") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":20100,"derivative":{"exercise_price":3.37,"exercise_date":"2022-06-02","expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":20100},"source":{"system":"sec-edgar","filing":"0001562180-21-004026","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1248144/000156218021004026/primarydocument.xml","form_type":"4"}},{"id":2682842,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-03T21:27:10.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":13700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (the \"RSUs\") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the \"2014 Plan\"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the \"Program\"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":91100,"source":{"system":"sec-edgar","filing":"0001562180-21-004026","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1248144/000156218021004026/primarydocument.xml","form_type":"4"}},{"id":3108795,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-16T23:13:39.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company."}],"balance_after":15000,"derivative":{"exercise_price":1.43,"exercise_date":"2021-06-16","expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-037077","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919120037077/doc4.xml","form_type":"4"}},{"id":3108794,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-16T23:13:39.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company."}],"balance_after":186250,"source":{"system":"sec-edgar","filing":"0001209191-20-037077","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919120037077/doc4.xml","form_type":"4"}},{"id":3110448,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-15T22:39:11.000Z","date":"2020-06-15","kind":"purchase","acquired":true,"shares":100000,"price":1.289,"value":128900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $1.27 to $1.30 on June 15, 2020. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":178750,"source":{"system":"sec-edgar","filing":"0001209191-20-036749","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919120036749/doc4a.xml","form_type":"4/A","original_submission_date":"2020-06-15"}},{"id":3110447,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-15T22:01:03.000Z","date":"2020-06-15","kind":"purchase","acquired":false,"shares":100000,"price":1.289,"value":128900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $1.27 to $1.30 on June 15, 2020. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":178750,"source":{"system":"sec-edgar","filing":"0001209191-20-036729","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919120036729/doc4.xml","form_type":"4"}},{"id":3116056,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2020-06-09T20:16:50.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the \"Stock Option\"). 100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":20100,"derivative":{"exercise_price":11.96,"exercise_date":"2021-06-05","expiration_date":"2030-06-05","underlying":"Common Stock","underlying_shares":20100},"source":{"system":"sec-edgar","filing":"0001562180-20-004354","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1248144/000156218020004354/primarydocument.xml","form_type":"4"}},{"id":3116055,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:16:50.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":13700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the \"RSUs\"). 100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":77400,"source":{"system":"sec-edgar","filing":"0001562180-20-004354","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1248144/000156218020004354/primarydocument.xml","form_type":"4"}},{"id":3362899,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-21T11:31:31.000Z","date":"2019-11-20","kind":"purchase","acquired":true,"shares":50000,"price":3.41,"value":170500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchase reported in this Form 4 was made on the open market."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.37 to $3.44, inclusive. The reporting person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":63700,"source":{"system":"sec-edgar","filing":"0001562180-19-005622","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1248144/000156218019005622/primarydocument.xml","form_type":"4"}},{"id":3478654,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-25T23:00:41.000Z","date":"2019-06-25","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Reporting Person's continuous service to the Company."}],"balance_after":7500,"derivative":{"exercise_price":2.19,"exercise_date":"2019-07-25","expiration_date":"2029-06-25","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-19-039018","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919119039018/doc4.xml","form_type":"4"}},{"id":3478653,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-25T23:00:41.000Z","date":"2019-06-25","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units shall vest in two equal consecutive annual installments on June 25, 2020 and June 25, 2021, subject to Reporting Person's continuous service to the Company."}],"balance_after":78750,"source":{"system":"sec-edgar","filing":"0001209191-19-039018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919119039018/doc4.xml","form_type":"4"}},{"id":3495516,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2019-06-10T20:03:48.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an option to purchase shares of the Issuer's common stock granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the \"Stock Option\").  100% of the Stock Option will vest and become exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":20100,"derivative":{"exercise_price":4.23,"exercise_date":"2020-06-06","expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":20100},"source":{"system":"sec-edgar","filing":"0001562180-19-003432","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1248144/000156218019003432/primarydocument.xml","form_type":"4"}},{"id":3495515,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-10T20:03:48.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":13700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended, as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the \"RSUs\").  100% of the RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":13700,"source":{"system":"sec-edgar","filing":"0001562180-19-003432","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1248144/000156218019003432/primarydocument.xml","form_type":"4"}},{"id":3731956,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2018-12-13T23:39:10.000Z","date":"2018-12-12","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter."}],"balance_after":25000,"derivative":{"exercise_price":8.94,"expiration_date":"2028-12-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-18-030946","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1248144/000089924318030946/doc4.xml","form_type":"4"}},{"id":3893718,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2018-06-14T22:19:16.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Optionee's Continuous Service to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% Acceleration upon Change of Control."}],"balance_after":15000,"derivative":{"exercise_price":4.125,"exercise_date":"2018-07-14","expiration_date":"2028-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-037854","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000120919118037854/doc4.xml","form_type":"4"}},{"id":4280627,"issuer":{"id":7102,"kind":"organization","name":"TALPHERA, INC."},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-15T21:17:33.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Issued pursuant to the 2011 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Optionee's Continuous Service on the Company's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% Acceleration upon Change of Control."}],"balance_after":15000,"derivative":{"exercise_price":2.3,"exercise_date":"2017-07-15","expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-17-011357","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427925/000143774917011357/rdgdoc.xml","form_type":"4"}},{"id":4322412,"issuer":{"id":165961,"kind":"organization","name":"Aralez Pharmaceuticals Inc.","symbol":"ARLZ"},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-05-13T01:53:27.000Z","date":"2017-05-11","kind":"grant","acquired":true,"shares":252316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 25% of the shares on May 11, 2018, and the remainder vests in substantially equal monthly installments over the 36 months immediately following such date, subject to continued employment or service to the Company."}],"balance_after":252316,"derivative":{"exercise_price":1.56,"expiration_date":"2027-05-11","underlying":"Common Shares, without par value","underlying_shares":252316},"source":{"system":"sec-edgar","filing":"0001104659-17-032416","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1248144/000110465917032416/a4.xml","form_type":"4"}},{"id":4322411,"issuer":{"id":165961,"kind":"organization","name":"Aralez Pharmaceuticals Inc.","symbol":"ARLZ"},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares, without par value","published_at":"2017-05-13T01:53:27.000Z","date":"2017-05-11","kind":"grant","acquired":true,"shares":218380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted Stock Units granted pursuant to the Aralez Pharmaceuticals Inc. 2016 Amended and Restated Long-Term Incentive Plan, which vest in substantially equal annual installments over the three years immediately following the date of grant, subject to continued employment or service to the Company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,027,668 shares of Common Stock and 1,759,942 Restricted Stock Units."}],"balance_after":3787610,"source":{"system":"sec-edgar","filing":"0001104659-17-032416","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1248144/000110465917032416/a4.xml","form_type":"4"}},{"id":4379533,"issuer":{"id":165961,"kind":"organization","name":"Aralez Pharmaceuticals Inc.","symbol":"ARLZ"},"owners":[{"id":35629,"kind":"person","name":"ADAMS ADRIAN","position":1,"cik":"0001248144","reported_name":"ADAMS ADRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares, without par value","published_at":"2017-03-17T20:16:24.000Z","date":"2017-03-15","kind":"purchase","acquired":true,"shares":500000,"price":2.4619,"value":1230950.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $2.305 to $2.600. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":3569230,"source":{"system":"sec-edgar","filing":"0001104659-17-017606","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1248144/000110465917017606/a4.xml","form_type":"4"}}]}